CCI Approves Advent's ₹3,150 Crore Investment in Yatharth Hospitals

The Competition Commission of India (CCI) has granted its approval for a substantial ₹3,150 crore investment by Advent International, a prominent US-based private equity firm, in Yatharth Hospital & Trauma Care Services. This clearance permits Advent to acquire a 24.9 percent stake in the hospital chain, marking a significant milestone in Yatharth’s growth strategy.

On September 17, 2026, Yatharth Hospitals officially announced that Advent International had signed a definitive agreement to inject ₹3,150 crore of primary capital into the company. This infusion is expected to provide fresh financial resources directly to Yatharth, enabling the hospital group to accelerate its expansion efforts.

Unlike secondary market transactions where investors purchase shares from existing stakeholders, this deal involves primary capital being invested straight into the company. The funds will support Yatharth’s plans to broaden its hospital network and enhance healthcare services. At present, Yatharth operates nine multi-speciality hospitals with a combined bed capacity of approximately 2,800. The hospital chain aims to nearly double this capacity to over 5,000 beds within the next three years.

Yatharth’s growth blueprint, as outlined in its fiscal year 2026 annual report, emphasizes increasing capacity, deepening clinical specializations, adopting advanced technologies, and expanding into underserved regions as well as high-growth catchment areas. These measures are designed to meet rising healthcare demand and improve patient outcomes.

Following the investment, Advent International will hold a significant minority stake in Yatharth Hospitals, while the founding Tyagi family will maintain its position as the largest shareholder. This partnership brings together Advent’s global investment expertise and Yatharth’s established presence in the Indian healthcare sector.

The CCI’s statement on the approval identified Rasmalai Limited as the acquiring entity. Rasmalai Limited is indirectly controlled by investment funds managed or advised by Advent and its affiliates. It currently has no operational activities or physical presence within India.

The Competition Commission of India plays a vital role in evaluating mergers and acquisitions that meet thresholds specified under the Competition Act, 2002. Its mandate is to ensure that such transactions do not negatively impact competition within relevant markets across India. While the CCI’s approval is a key step forward, a detailed official order from the commission is awaited to provide further insights into the assessment process.

This investment comes at a time when the Indian healthcare sector is witnessing increased interest from private equity firms and investors, drawn by the growing demand for quality medical services and infrastructure. Expansion of hospital networks, especially in tier 2 and tier 3 cities, is a notable trend as healthcare providers seek to fill gaps in accessibility and specialized care.

Advent International’s involvement in Yatharth Hospitals underscores the importance of private capital in strengthening healthcare infrastructure. With rising patient volumes and evolving clinical needs, hospitals require significant investment to upgrade facilities, introduce cutting-edge medical technologies, and recruit skilled professionals.

Yatharth Hospitals has built a reputation for multi-speciality care, and this new capital injection is poised to support its vision for becoming a leading healthcare provider with enhanced capacity and service offerings. The combined experience of the Tyagi family and Advent’s global perspective could shape the future trajectory of the hospital chain in India’s competitive healthcare market.